Ad hoc Announcement according to Art. 17 Market Abuse Regulation
May 06 2019

Ad hoc Announcement according to Art. 17 Market Abuse Regulation

QIAGEN to conduct an additional up to $100 million share repurchase program

Venlo, The Netherlands, May 6, 2019 – QIAGEN N.V. announces that its Managing Board, upon authorization of the Supervisory Board, has today passed a resolution to exercise the authorization granted by the General Meeting of Shareholders on June 19, 2018, and to purchase shares in the Company up to a total of $100 million (or the equivalent Euro amount thereof, in each case excluding transaction costs). Based on the closing price on May 3, 2019, this represents a repurchase volume of approximately 2.5 million shares. The repurchase program is scheduled to begin at the earliest after completion of the current share repurchase program that was announced through an ad hoc announcement on January 31, 2018, and to be completed on December 19, 2019, at the latest, or if the upcoming General Meeting of Shareholders will extend the authorization to repurchase shares, on December 17, 2020, at the latest.  Details of the repurchase program will be announced before its actual commencement in line with Article 5 Section (1) and (6) of the EU regulation 596/2014 in conjunction with the regulatory technical standards adopted by the European Commission (so called Safe Harbour Regulation). Repurchased shares will be held in treasury in order to satisfy obligations from employee share-based remuneration plans.

QIAGEN N.V.

Hulsterweg 82

5912 PL Venlo

The Netherlands

ISIN: NL0012169213

Frankfurt Stock Exchange, Regulated Market (Prime Standard)

 

Contacts QIAGEN N.V.:

Corporate Communications

John Gilardi, Tel: +49 2103 29 11711; ir@qiagen.com

Thomas Theuringer, Tel: +49 2013 29 11826 pr@qiagen.com
FOLLOW US ON SOCIAL MEDIA

Share this page